Extracorporeal photopheresis: How, when, and why

Journal of Clinical Apheresis

Volumn 26, Issue 5, 2011, Pages 276-285

  Ward, David M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

photopheresis; therapeutic apheresis academy

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOCYTE ANTIBODY; METHOXSALEN; METHYLPREDNISOLONE; PSORALEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ATOPIC DERMATITIS; BLOOD FILTRATION; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRIFUGATION; CROHN DISEASE; CUTANEOUS T CELL LYMPHOMA; CYTOTOXIC T LYMPHOCYTE; DNA CROSS LINKING; DRUG MEGADOSE; ERYTHRODERMA; EXTRACORPOREAL PHOTOPHERESIS; FEVER; GRAFT VERSUS HOST REACTION; HEMATOCRIT; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; LEUKOCYTE; LICHEN PLANUS; LIVER GRAFT REJECTION; LOW DRUG DOSE; LUNG GRAFT REJECTION; LYMPHOCYTE FUNCTION; MEDICAL INSTRUMENTATION; MYCOSIS FUNGOIDES; NEPHROGENIC SYSTEMIC FIBROSIS; OFF LABEL DRUG USE; PATIENT SAFETY; PEMPHIGUS VULGARIS; PHOTOSENSITIZATION; PUVA; REGULATORY T LYMPHOCYTE; REVIEW; SEZARY SYNDROME; SKIN DISEASE; SURVIVAL TIME; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TREATMENT CONTRAINDICATION;

BLOOD COMPONENT REMOVAL; CROHN DISEASE; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNE SYSTEM DISEASES; LEUKOCYTES; LYMPHOMA, T-CELL, CUTANEOUS; MALE; PHOTOPHERESIS; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 80054075734     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20300     Document Type: Review

References (64)

1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G, McKiernan G, Christiansen I, Oster M, Honigsmann H, Wilford H, Kokoschka E, Rehle T, Perez M, Stingl G, Laroche L,. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 1987; 316: 297-303. (Pubitemid 17036377)
2. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH, Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. JClin Apheresis 2010; 25: 83-177.
3. Ward DM,. Therapeutic plasmapheresis and related apheresis techniques. In:, Petersdorf R, Adams R, Braunwald E, Isselbacher K, Martin J, Wilson J, editors. Updates to Harrison's Principles of Internal Medicine. Volume 5. Philadelphia: Williams and Wilkins. 1984. pp 67-95.
4. Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, Papworth GD, Wang Z, Watkins SC, Falo LD Jr, Thomson AW,. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101: 611-620. (Pubitemid 36077584)
5. Fimiani M, Di Renzo M, Rubegni P,. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Br J Dermatol 2004; 150: 1055-1060. (Pubitemid 38932273)
6. Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A, Cenci F, Bottazzo GF, Carsetti R,. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005; 9: 846-850. (Pubitemid 40546206)
7. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D, Schwarz T,. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen specific regulatory T cells. J Immunol 2005; 174: 5968-5976. (Pubitemid 40663783)
8. Maeda A, Schwarz A, Bullinger A, Peritt D, Schwartz T,. Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol 2008; 181: 5956-5962.
9. George JF, Gooden CW, Guo L, Kirklin JK,. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis. J Heart Lung Transplant 2008; 27: 616-622. (Pubitemid 351707621)
10. Gatza E, Rogers CE, Clouthier SG, Lowler KP, Tawara I, Liu C, Reddy P, Ferrara JL,. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008; 112: 1515-1521.
11. Diawara MM, Kulkosky PJ,. Reproductive toxicity of the psoralens. Pediatr Pathol Mol Med 2003; 22: 247-258. (Pubitemid 36548154)
12. st, 2011.
13. Zic JA,. The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatol Ther 2003; 16: 337-346. (Pubitemid 38044678)
14. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R,. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095-1107. (Pubitemid 38058085)
15. Knobler R, Barr ML, Couriel DR, Ferrara JL, French LE, Jaksch P, Reinisch W, Rook AH, Schwarz T, Greinix H,. Extracorporeal photopheresis: past, present and future. J Am Acad Dermatol 2009; 61: 652-665.
16. Dall'Amico, Messina C,. Extracorporeal photochemotherapy for the treatment of graft-versus-host-disease. Ther Apheresis 2002; 6: 296-304.
17. Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P, Mitterbauer M, Rabitsch W, Schulenburg A, Kalhs P,. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006; 91: 405-408.
18. Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello G, Cesaro S, Pillon M, Perotti C, Del Fante C, Faraci M, Rivabella L, Calore E, De Stefano P, Zecca M, Giorgiani G, Brugiolo A, Balduzzi A, Dini G, Zanesco L, Dall'Amico R. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 118-127. (Pubitemid 36819346)
19. Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, Chan G, Stiffler K, Miller KB,. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005; 35: 1187-1193. (Pubitemid 40895175)
20. Apisarnthanarax N, Donato M, Korbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P,. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003; 31: 459-465. (Pubitemid 36511812)
21. Flowers ME, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V, Bacigalupo A, Kolb HJ, Bouzas L, Michallet M, Prince HM, Knobler R, Parenti D, Gallo J, Greinix HT,. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008; 112: 2667-2674.
22. Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu Y, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M,. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107: 3074-3080.
23. Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL, Vaughan LA, Kassim A, Schuening F, Jagasia M,. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allogeneic stem cell transplant. Bone Marrow Transplant 2010; 1: 4.
24. Rose EA, Barr ML, Xu H, Pepino P, Murphy MP, McGovern MA, Ratner AJ, Watkins JF, Marboe CC, Berger CL,. Photochemotherapy in human heart transplant recipients at high risk for fatal rejection. J Heart Lung Transplant 1992; 11: 746-750.
25. Wieland M, Thiede VL, Strauss RG, Piette WW, Kapelanski DP, Landas SK, Hunsicker LG, Vance SJ, Randels MJ,. Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy. J Clin Apheresis 1994; 9: 171-175.
26. Dall'Amico R, Livi U, Milano A, Montini G, Andreetta B, Murer L, Zacchello G, Thiene G, Casarotto D, Zacchello F,. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection. Transplantation 1995; 60: 45-49.
27. Dall'Amico R, Montini G, Murer L, Andreetta B, Andreetta B, Zacchello G, Gambino A, Feltrin G, Caforio A, Tursi V, Livi U,. Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection. Int J Artif Organs 2000; 23: 49-54. (Pubitemid 30116415)
28. Lehrer MS, Rook AH, Tomaszewski JE, DeNofrio D,. Successful reversal of severe refractory cardiac allograft rejection by photopheresis. J Heart Lung Transplant 2001; 20: 1233-1236. (Pubitemid 33035087)
29. Barr M, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall', Amico R, Dorent R, Rogers JG, Radovancević B, Taylor DO, Jeevanandam V, Marboe CC,. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med 1998; 339: 1744-1751. (Pubitemid 28555433)
30. Barr M, Baker CJ, Schenkel FA, McLaughlin SN, Stouch BC, Starnes VA, Rose EA,. Prophylactic photopheresis and chronic rejection: effects of graft intimal hyperplasia in cardiac transplantation. Clin Transplantation 2000; 14: 162-166. (Pubitemid 30171218)
31. Kirklin JK, Brown RN, Huang ST, Naftel DC, Hubbard SM, Rayburn BK, McGiffin DC, Bourge RB, Benza RL, Tallaj JA, Pinderski LJ, Pamboukian SV, George JF, Marques M,. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 2006; 25: 283-288. (Pubitemid 43290657)
32. Zheng DH, Dou LP, Wei YX, Du GS, Zou YP, Song JY, Zhu ZD, Cai M, Qian YY, Shi BY,. Uptake of donor lymphocytes treated with 8-methoxypsoralen and ultraviolet A light by recipient dendritic cells induces CD4+CD25+Foxp3+ regulatory T cells and down-regulates cardiac allograft rejection. Biochem Biophys Res Commun 2010; 395: 540-546.
33. Andreu G, Achkar A, Couetil JP, Guillemain R, Heshmati F, Amrein C, Chevalier P, Guinvarch A, Dore MF, Capron F,. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant 1995; 14: 793-796.
34. Slovis BS, Loyd JE, King LE,. Photopheresis for chronic rejection of lung allografts. N Engl J Med 1995; 332: 962.
35. O'Hagan AR, Stillwell PC, Arroliga A, Koo A,. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 1999; 115: 1459.
36. Salerno CT, Park SJ, Kreykes NS, Kulick DM, Savik K, Hertz MI, Bolman RM,. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg 1999; 117: 1063-1069. (Pubitemid 29270344)
37. Villanueva J, Bhorade SM, Robinson JA, Husain AN, Garrity ER,. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 2000; 5: 44-47.
38. Benden C, Speich R, Hofbauer GF, Irani S, Eich-Wanger C, Russi EW, Weder W, Boehler A,. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008; 86: 1625-1627.
39. Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR,. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplantation 2010; 29: 424.
40. Lehrer MS, Ruchelli E, Olthoff KM, French LE, Rook AH,. Successful reversal of recalcitrant hepatic allograft rejection by photopheresis. Liver Transpl 2000; 6: 644-647.
41. Urbani L, Mazzoni A, Catalano G, De Simone P, Vanacore R, Pardi C, Bortoli M, Biancofiore G, Campani D, Perrone V, Mosca F, Scatena F, Filipponi F,. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients. Transplant Proc 2004; 36: 3068-3070. (Pubitemid 41126742)
42. Urbani L, Mazzoni A, Colombatto P, Bindi L, Biancofiore G, Tascini C, Menichetti F, Brunetto MR, Scatena F, Filipponi F,. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers. Transplantation 2008; 86: 1666-1671.
43. Urbani L, Mazzoni A, Colombatto P, Biancofiore G, Bindi L, Tascini C, Menichetti F, Brunetto M, Scatena F, Filipponi F,. Potential applications of extracorporeal photopheresis in liver transplantation. Transplant Proc 2008; 40: 1175-1178. (Pubitemid 351794321)
44. Dall'Amico R, Murer L, Montini G, Andreetta B, Zanon GF, Zacchello G, Zacchello F,. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 1998; 9: 121-127. (Pubitemid 28050053)
45. Baron ED, Heeger PS, Hricik DE, Schulak JA, Tary-Lehmann M, Stevens SR,. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17: 79-82. (Pubitemid 32280063)
46. Wolfe JT, Tomaszewski JE, Grossman RA, et al. Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature. J Clin Apheresis 1996; 11: 36-41. (Pubitemid 26137448)
47. Genberg H, Kumlien G, Shanwell A, Tyden G,. Refractory acute renal allograft rejection successfully treated with photopheresis. Transplant Proc 2005; 37: 3288-3289. (Pubitemid 41659867)
48. Kumlien G, Genberg H, Shanwell A, Tyden G,. Photopheresis for the treatment of refractory renal graft rejection. Transplantation 2005; 79: 123-125. (Pubitemid 40140011)
49. Lamioni A, Carsetti R, Legato A, Landolfo A, Isacchi G, Emma F, Bottazzo GF, Dello Strologo L,. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 2007; 83: 1393-1396. (Pubitemid 46800319)
50. Jardine MJ, Bhandari S, Wyburn KR, Misra AK, McKenzie PR, Eris JM,. Photopheresis therapy for problematic renal allograft rejection. J Clin Apheresis 2009; 24: 161-169.
51. Rook AH, Freundlich B, Nahass GT, Washko R, Macelis B, Skolnicki M, Bromley P, Witmer WK, Jegasothy BV,. Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis. Yale J Biol Med 1989; 62: 639-645. (Pubitemid 20201944)
52. Fimiani M, Rubegni P, Flori ML, Mazzatenta C, D', Ascenzo G, Andreassi L,. Three cases of progressive systemic sclerosis treated with extracorporeal photochemotherapy. Arch Dermatol Res 1997; 289: 120-122. (Pubitemid 27075579)
53. Krasagakis K, Dippel E, Ramaker J, Owsianowski M, Orfanos CE,. Management of severe scleroderma with long-term extracorporeal photopheresis. Dermatology 1998; 196: 309-315. (Pubitemid 28224811)
54. Muellegger RR, Hofer A, Salmhofer W, Soyer HP, Kerl H, Wolf P,. Extended extracorporeal photochemotherapy with extracorporeal administration of 8-methoxypsoralen in systemic sclerosis: an Austrian single-center study. Photodermatol Photoimmunol Photomed 2000; 16: 216-223.
55. Di Spaltro FX, Cottrill C, Cahill C, Degnan E, Mulford GJ, Scarborough D, Franks AJ Jr, Klainer AS, Bisaccia E,. Extracorporeal photochemotherapy in progressive systemic sclerosis. Int J Dermatol 1993; 32: 417-421. (Pubitemid 23189887)
56. Schwartz J, Gonzalez J, Palangio M, Klainer AS, Bisaccia E,. Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow-up study. Int J Dermatol 1997; 36: 380-385. (Pubitemid 27278508)
57. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahaleh MB, Varga J,. Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial. Arch Dermatol 1992; 128: 337-346.
58. Enomoto DN, Mekkes JR, Bossuyt PM, Yong SL, Out TA, Hoekzema R, de Rie MA, Schellekens PT, ten, Berge IJ, de Borgie CA, Bos JD,. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol 1999; 41: 915-922.
59. Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, Strobl FJ, Keystone E, Mehlmauer M, Rook AH, Braverman I, Systemic Sclerosis Study Group. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006; 54: 793-799.
60. Reinisch W, Nahavandi H, Santella R, Zhang Y, Gasché C, Moser G, Waldhör T, Gangl A, Vogelsang H, Knobler R,. Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study. Aliment Pharmacol Ther 2001; 15: 1313-1322. (Pubitemid 32835537)
61. Guariso G, D'Inca R, Sturniolo GC, Zancan L, Dall'Aminco R,. Photopheresis treatment in severe Crohn disease. J Pediatr Gastroenterol Nutr 2003; 37: 517-520.
62. Abreu MT, von Tirpitz C, Hardi R, Kaatz M, Van Assche G, Rutgeerts P, Bisaccia E, Goerdt S, Hanauer S, Knobler R, Mannon P, Mayer L, Ochsenkuhn T, Sandborn WJ, Parenti D, Lee K, Reinisch W, Crohn's Disease Photopheresis Study Group. Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study. Inflamm Bowel Dis 2009; 15: 829-836.
63. Gollnick HP, Owsianowski M, Taube KM, Orfanos CE,. Unresponsive severe generalized pemphigus vulgaris successfully controlled by photopheresis. J Am Acad Dermatol 1993; 28: 122-124. (Pubitemid 23019586)
64. Hivelin M, Siemionow M, Grimbert P, Lantieri L,. Extracorporeal photopheresis: from solid organs to face transplantation. Transplant Immunol 2009; 21: 117-128.